Latest Johnson & Johnson News
Johnson & Johnson: Q1 Earnings Snapshot
NEW BRUNSWICK, N.J. (AP) — NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson (JNJ) on Tuesday reported first-quarter profit of $5.35 billion. On a per-share basis, the New Brunswick, New Jersey-based company said it had net income of $2.20. Earnings, adjusted for one-time gains...
Newmont, Shockwave Medical rise; John Bean falls, Friday, 4/4/2024
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Friday: Shockwave Medical Inc., up $6.35 to $326.34. Johnson & Johnson is buying the medical device company in a deal worth about $13.1 billion. Norfolk Southern Corp.,...
J&J to pump another $13B into its MedTech business with Shockwave deal
Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries. The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The...
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Wednesday: Merck & Co., up $6.23 to $131.75. The drug developer received U.S. approval for a high blood pressure treatment. Shockwave Medical Inc., up $6.54 to $322.61....
Amazon joins 29 other 'blue chip' companies in the Dow Jones Industrial Average
Amazon.com Inc. is joining the ranks of one of Wall Street's oldest and most exclusive stock indexes: The Dow Jones Industrial Average. The e-commerce pioneer will officially take its position among the 30-company Dow before the open of trading Monday, replacing drugstore operator...
Washington state reaches a nearly $150 million settlement with Johnson & Johnson over opioid crisis
OLYMPIA, Wash. (AP) — The Washington state attorney general announced a $149.5 million settlement Wednesday with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role in the opioid addiction crisis. "They knew what the harm was. They...
